A pilot study for detection of safety and effect of Combretastatin A4 phosphate injection combined with paclitaxel, Carboplatin in the treatment of head and neck advanced solid tumor
Phase of Trial: Phase II
Latest Information Update: 02 May 2016
Price : $35 *
At a glance
- Drugs Fosbretabulin (Primary) ; Carboplatin; Paclitaxel
- Indications Head and neck cancer
- Focus Therapeutic Use
- 30 Apr 2016 Status changed from active, no longer recruiting to completed.
- 30 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 03 Feb 2014 Status changed from not yet recruiting to recruiting as reported by the Chinese Clinical Trial Register record.